TON - August 2010, Vol 3, No 5

TON - August 2010, Vol 3, No 5 — September 14, 2010

CHICAGO—Several new agents elicited excitement for the treatment of women with advanced breast cancer, including a novel cytotoxic agent that is the first to improve survival as mono therapy in this challenging patient population.

In an international study, patients with metastatic breast cancer refractory to numerous treatments lived 2.5 months longer when treated with eribulin mesylate, a synthetic analog of the novel halichondrin B family, versus single agents alone.

Read More ›

TON - August 2010, Vol 3, No 5 — September 14, 2010

SAN FRANCISCO—Two new studies presented at the 2010 annual meeting of the American Urological Association (AUA) suggest that large-scale prostate cancer screenings can indeed save lives.

Researchers in Innsbruck, Austria, evaluated data from the state of Tyrol within Austria, where an early detection and treatment program has been in place for more than 20 years. They found that these programs have been associated with a reduction in mortality in areas where effective treatment is available to all men.

Read More ›

TON - August 2010, Vol 3, No 5 — September 14, 2010

SAN FRANCISCO—Prostate cancer patients undergoing three-dimensional external beam radiation therapy (3DEBRT) for prostate cancer may be at an increased risk of hip fracture and could benefit from additional measures to improve bone health following treatment, according to a study by Minneapolis researchers. Read More ›


TON - August 2010, Vol 3, No 5 — September 14, 2010

Once-yearly Histrelin Implant Provides Sustained Improvement in Prostate Cancer Patients

BARCELONA—Investigators have documented the long-term efficacy and tolerability of a once-yearly histrelin subdermal implant in men with advanced prostate cancer.

Read More ›

TON - August 2010, Vol 3, No 5 — September 14, 2010
Rita Wickham, PhD, RN, AOCN, of Rapid River, Michigan, received the Rose Mary Carroll-Johnson Distinguished Award for Consistent Contribution to Nursing Literature at the 35th Annual Congress of the Oncology Nursing Society (ONS). Read More ›

TON - August 2010, Vol 3, No 5 — September 14, 2010
Skin Cancer, edited by Paula Muehlbauer and Christine McGowan, is the first publication in the Oncology Nursing Society’s Site-Specific Cancer Series. Read More ›

TON - August 2010, Vol 3, No 5 — September 13, 2010

SAN DIEGO—Oncology nurses can implement simple measures to ensure the safe disposal of cytotoxic therapies, according to Baltimore researchers.

The measures are aimed at reducing the hazards posed by chemotherapy disposal to neighboring communities and the environment.

According to standard policy at most cancer centers, chemo therapy waste is collected in designated yellow plastic containers, which are disposed of as regulated medical waste and incinerated,

Read More ›

TON - August 2010, Vol 3, No 5 — September 13, 2010

SAN DIEGO—Creative strategies used by local chapters of the Oncology Nursing Society (ONS) to recruit and retain members and reach out to their local communities were described in poster presentations at the 2010 Congress. Using these strategies, the chapters not only increased membership but also strengthened ties with their communities.

San Diego ONS chapter meets goal of 210 by 2010

Read More ›

TON - August 2010, Vol 3, No 5 — September 13, 2010

SAN DIEGO—Oncology nurses who work in an adult community–based practice can remain abreast of new information provided that a range of options for continuing education (CE) is available, according to a new study.

Read More ›

TON - August 2010, Vol 3, No 5 — September 12, 2010

CHICAGO—Cancer patients and survivors should strive to get 150 minutes per week of moderate-intensity aerobic exercise, according to new national guidelines. That is the same recommendation for the general public.

Although the evidence indicates that most types of physical activity, from swimming to yoga to strength training, are beneficial for cancer patients, the guidelines say clinicians should tailor exercise recommendations to individual patients.

Read More ›

Page 1 of 2


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: